$OPCH
Option Care Health, Inc. Stock $opch

$opch Overview Financials Valuation SEC Filings Company Website

2016 Q3 Form 10-Q Financial Statement

#000162828016018661 Filed on August 08, 2016

Income Statement

Concept	2016 Q3	2016 Q2	2015 Q2
Revenue	$224.5M	$232.5M	$246.9M
YoY Change	-9.17%	-5.85%	-0.09%
Cost Of Revenue	$162.0M	$168.3M	$182.1M
YoY Change	-11.01%	-7.57%	0.17%
Gross Profit	$61.72M	$63.27M	$64.82M
YoY Change	-5.38%	-2.39%	4.13%
Gross Profit Margin	27.49%	27.22%	26.25%
Selling, General & Admin	$17.70M	$13.70M	$27.00M
YoY Change	-1.12%	-49.26%	-54.85%
% of Gross Profit	28.68%	21.65%	41.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.200M	$4.300M	$4.130M
YoY Change	4.24%	4.12%	4.35%
% of Gross Profit	6.8%	6.8%	6.37%
Operating Expenses	$64.50M	$58.60M	$76.50M
YoY Change	-1.68%	-23.4%	34.92%
Operating Profit	-$2.779M	$4.666M	-$254.0M
YoY Change	-85.59%	-101.84%	3860.78%
Interest Expense	-$9.300M	-$9.500M	-$9.100M
YoY Change	-2.11%	4.4%	-199.62%
% of Operating Profit		-203.6%
Other Income/Expense, Net
YoY Change
Pretax Income	-$11.01M	-$8.770M	-$264.8M
YoY Change	-61.75%	-96.69%	1437.79%
Income Tax	$421.0K	$149.0K	-$19.92M
% Of Pretax Income
Net Earnings	-$11.33M	-$8.750M	-$244.8M
YoY Change	-32.51%	-96.43%	1135.28%
Net Earnings / Revenue	-5.04%	-3.76%	-99.15%
Basic Earnings Per Share
Diluted Earnings Per Share	-$393.7K	-$448.1K	-$14.23M
COMMON SHARES
Basic Shares Outstanding	113.9M shares	68.78M shares	68.65M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q3	2016 Q2	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.800M	$51.40M	$1.200M
YoY Change	-90.48%	4183.33%	-20.0%
Cash & Equivalents	$2.835M	$51.43M	$1.173M
Short-Term Investments
Other Short-Term Assets	$19.50M	$16.50M	$10.40M
YoY Change	-10.96%	58.65%	-15.45%
Inventory	$33.38M	$32.45M	$42.36M
Prepaid Expenses
Receivables	$103.7M	$98.60M	$131.5M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$159.4M	$199.0M	$185.4M
YoY Change	-20.08%	7.34%	-22.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$33.71M	$30.79M	$34.91M
YoY Change	-1.16%	-11.79%	-12.43%
Goodwill	$373.1M	$308.7M	$335.3M
YoY Change	20.84%	-7.93%	-41.47%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.055M	$1.203M	$1.192M
YoY Change	77.46%	0.92%	-9.56%
Total Long-Term Assets	$436.0M	$344.2M	$391.7M
YoY Change	20.04%	-12.13%	-39.27%
TOTAL ASSETS
Total Short-Term Assets	$159.4M	$199.0M	$185.4M
Total Long-Term Assets	$436.0M	$344.2M	$391.7M
Total Assets	$595.4M	$543.2M	$577.1M
YoY Change	5.82%	-5.87%	-34.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$45.70M	$48.89M	$77.09M
YoY Change	-14.39%	-36.58%	10.52%
Accrued Expenses	$43.10M	$39.90M	$47.60M
YoY Change	-14.48%	-16.18%	4.16%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$48.20M	$9.400M	$200.0K
YoY Change	21.72%	4600.0%	-50.0%
Total Short-Term Liabilities	$140.9M	$101.7M	$134.0M
YoY Change	-4.03%	-24.15%	6.72%
LONG-TERM LIABILITIES
Long-Term Debt	$388.1M	$390.1M	$418.6M
YoY Change	-5.18%	-6.81%	0.07%
Other Long-Term Liabilities	$4.502M	$1.655M	$6.891M
YoY Change	-33.73%	-75.98%	-19.68%
Total Long-Term Liabilities	$4.502M	$1.655M	$6.891M
YoY Change	-33.73%	-75.98%	-19.68%
TOTAL LIABILITIES
Total Short-Term Liabilities	$140.9M	$101.7M	$134.0M
Total Long-Term Liabilities	$4.502M	$1.655M	$6.891M
Total Liabilities	$550.1M	$494.0M	$562.5M
YoY Change	-2.3%	-12.17%	-1.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$630.9M	-$619.7M	-$566.7M
YoY Change	8.14%	9.35%	183.53%
Common Stock	$606.7M	$612.6M	$534.1M
YoY Change	13.81%	14.7%	1.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00	$11.01M	$10.72M
YoY Change	-100.0%	2.74%	3.92%
Treasury Stock Shares	0.000 shares	2.761M shares	2.645M shares
Shareholders Equity	-$24.28M	-$18.08M	-$43.29M
YoY Change
Total Liabilities & Shareholders Equity	$595.4M	$543.2M	$577.1M
YoY Change	5.82%	-5.87%	-34.7%

Cashflow Statement

Concept	2016 Q3	2016 Q2	2015 Q2
OPERATING ACTIVITIES
Net Income	-$11.33M	-$8.750M	-$244.8M
YoY Change	-32.51%	-96.43%	1135.28%
Depreciation, Depletion And Amortization	$4.200M	$4.300M	$4.130M
YoY Change	4.24%	4.12%	4.35%
Cash From Operating Activities	-$16.90M	-$10.60M	-$18.20M
YoY Change	-17.16%	-41.76%	264.0%
INVESTING ACTIVITIES
Capital Expenditures	-$2.500M	-$3.100M	-$3.700M
YoY Change	-41.86%	-16.22%	-2.63%
Acquisitions
YoY Change
Other Investing Activities	-$64.40M	$0.00	$0.00
YoY Change	-387.5%		-100.0%
Cash From Investing Activities	-$67.10M	-$3.000M	-$3.700M
YoY Change	-472.78%	-18.92%	12.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	35.40M	57.00M	-200.0K
YoY Change	15.31%	-28600.0%	-140.0%
NET CHANGE
Cash From Operating Activities	-16.90M	-10.60M	-18.20M
Cash From Investing Activities	-67.10M	-3.000M	-3.700M
Cash From Financing Activities	35.40M	57.00M	-200.0K
Net Change In Cash	-48.60M	43.40M	-22.10M
YoY Change	-271.73%	-296.38%	183.33%
FREE CASH FLOW
Cash From Operating Activities	-$16.90M	-$10.60M	-$18.20M
Capital Expenditures	-$2.500M	-$3.100M	-$3.700M
Free Cash Flow	-$14.40M	-$7.500M	-$14.50M
YoY Change	-10.56%	-48.28%	1108.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q4	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	52918000	USD
CY2016Q2	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	33158000	USD
CY2015Q2	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	5969000	USD
	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	9673000	USD
CY2016Q2	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	4291000	USD
	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	6958000	USD
CY2015Q4	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	3491000	USD
CY2016Q2	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	3553000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-322000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8790000	USD
CY2015Q2	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	93000	USD
	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	72000	USD
CY2016Q2	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	-51000	USD
	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	-102000	USD
	bios	Increase Decreasein Amounts Due To Plan Sponsor IncreaseDecreaseinAmountsDueToPlanSponsor	-1403000	USD
	bios	Increase Decreasein Amounts Due To Plan Sponsor IncreaseDecreaseinAmountsDueToPlanSponsor	62000	USD
	bios	Increase Decreasein Fair Valueof Contingent Consideration IncreaseDecreaseinFairValueofContingentConsideration	72000	USD
	bios	Increase Decreasein Fair Valueof Contingent Consideration IncreaseDecreaseinFairValueofContingentConsideration	-102000	USD
CY2015Q4	bios	Long Term Debt And Capital Lease Obligations Total LongTermDebtAndCapitalLeaseObligationsTotal	418121000	USD
CY2016Q2	bios	Long Term Debt And Capital Lease Obligations Total LongTermDebtAndCapitalLeaseObligationsTotal	399459000	USD
	bios	Proceedsfrom Issuanceof Convertible Preferred Stockand Warrants ProceedsfromIssuanceofConvertiblePreferredStockandWarrants	58951000	USD
	bios	Proceedsfrom Issuanceof Convertible Preferred Stockand Warrants ProceedsfromIssuanceofConvertiblePreferredStockandWarrants	0	USD
CY2015Q1	bios	Proceedsfrom Issuanceof Equityand Temporary Equity ProceedsfromIssuanceofEquityandTemporaryEquity	62500000	USD
CY2015Q3	bios	Proceedsfrom Issuanceof Equityand Temporary Equity ProceedsfromIssuanceofEquityandTemporaryEquity	1100000	USD
CY2016Q2	bios	Saleof Stock Equity Issuable Amount SaleofStockEquityIssuableAmount	200000000	USD
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001014739
CY2016Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	113880241	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	BioScrip, Inc.
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	65077000	USD
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	48887000	USD
CY2015Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	157042000	USD
CY2016Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	149948000	USD
CY2015Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	97353000	USD
CY2016Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	98634000	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	531764000	USD
CY2016Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	612603000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	59689000	USD
CY2016Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	51314000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	59689000	USD
CY2016Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	51314000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1792000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1989000	USD
CY2015Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6247000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12041000	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4252000	USD
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6100000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5600000	shares
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14000000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15500000	shares
CY2015Q4	us-gaap	Assets Assets	530642000	USD
CY2016Q2	us-gaap	Assets Assets	543247000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	183685000	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	199014000	USD
CY2015Q2	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	1664000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	1884000	USD
CY2016Q2	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	2924000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	2924000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	753000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	740000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1173000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15577000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51425000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	433000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	35848000	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1994000	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-5913000	USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71421664	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	116641664	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68767613	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	113880241	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	12000	USD
CY2015Q2	us-gaap	Cost Of Revenue CostOfRevenue	182079000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	361481000	USD
CY2016Q2	us-gaap	Cost Of Revenue CostOfRevenue	168298000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	342528000	USD
CY2015Q2	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2016Q2	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2015Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	29000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	30000	USD
CY2016Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	25000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	25000	USD
CY2015Q2	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	29000	USD
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	30000	USD
CY2016Q2	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	25000	USD
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	25000	USD
CY2015Q2	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-16816000	USD
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-15188000	USD
CY2016Q2	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	108000	USD
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	125000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	238000000	USD
CY2016Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	64818000	USD
	us-gaap	Gross Profit GrossProfit	129773000	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	64164000	USD
CY2015Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	15863000	USD
CY2016Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	14181000	USD
CY2015Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-19950000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-18023000	USD
CY2016Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	124000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	147000	USD
CY2015Q2	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3134000	USD
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2835000	USD
CY2016Q2	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	16000	USD
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	22000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Gross Noncurrent DeferredTaxLiabilitiesGrossNoncurrent	236000	USD
CY2016Q2	us-gaap	Deferred Tax Liabilities Gross Noncurrent DeferredTaxLiabilitiesGrossNoncurrent	589000	USD
	us-gaap	Depreciation Depreciation	12041000	USD
	us-gaap	Depreciation Depreciation	8790000	USD
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.62
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.93
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.32
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5128000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3512000	USD
CY2015Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2016Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	939000	USD
CY2015Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11866000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23565000	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9414000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20465000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	308729000	USD
CY2016Q2	us-gaap	Goodwill Goodwill	308729000	USD
CY2015Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	238000000	USD
	us-gaap	Gross Profit GrossProfit	128396000	USD
CY2015Q2	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	246897000	USD
	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	491254000	USD
CY2016Q2	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	232462000	USD
	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	470924000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-244902000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-262196000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8309000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-18078000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-264823000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-280189000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-8160000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-17906000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-3.62
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-3.90
CY2016Q2	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.14
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.32
CY2015Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	94000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-2285000	USD
CY2016Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	75000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	308000	USD
CY2015Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.03
CY2016Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-19921000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-17993000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	149000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	172000	USD
CY2015Q2	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	31098000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	37879000	USD
CY2016Q2	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1926000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5314000	USD
CY2015Q2	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-92080000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-96972000	USD
CY2016Q2	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2844000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6271000	USD
CY2015Q2	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	40977000	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	40977000	USD
CY2016Q2	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	USD
CY2015Q2	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	73000	USD
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	112000	USD
CY2016Q2	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	1064000	USD
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	1126000	USD
CY2015Q2	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	11000	USD
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	11000	USD
CY2016Q2	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	3000	USD
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	3000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	515000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	229000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-12728000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-16190000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	15834000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-352000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-148000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-192000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5149000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10537000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-8530000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-3140000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	691000	USD
CY2016Q2	us-gaap	Liabilities Liabilities	494007000	USD
	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	4054000	USD
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-248799000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-7933000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	1281000	USD
CY2015Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9080000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-18243000	USD
CY2016Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9469000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-18881000	USD
	us-gaap	Interest Paid Net InterestPaidNet	18391000	USD
	us-gaap	Interest Paid Net InterestPaidNet	17325000	USD
CY2015Q4	us-gaap	Interest Payable Current InterestPayableCurrent	6898000	USD
CY2016Q2	us-gaap	Interest Payable Current InterestPayableCurrent	6706000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	42983000	USD
CY2016Q2	us-gaap	Inventory Net InventoryNet	32446000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	548602000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	530642000	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	543247000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	152764000	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	101661000	USD
CY2016Q2	us-gaap	Long Term Debt LongTermDebt	412828000	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	393741000	USD
CY2016Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	390102000	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	24380000	USD
CY2016Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	9357000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	52390000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	61771000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5797000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4334000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-46160000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21589000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-44166000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-15676000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-244808000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-264481000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-8234000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-17770000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-270089000	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10463000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22169000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1161000	USD
CY2016Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1203000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1861000	USD
CY2016Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1655000	USD
CY2015Q2	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	43314000	USD
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	84929000	USD
CY2016Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30789000	USD
CY2016Q2	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	40619000	USD
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	80277000	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	5797000	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	5466000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1218000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	7133000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4175000	shares
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4175000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	27772000	USD
CY2016Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16509000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	83267000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	129163000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	45000000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	2000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-93000	USD
	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	0	USD
	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-6274000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1132000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31939000	USD
CY2015Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	15165000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	23511000	USD
CY2016Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4279000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	11870000	USD
CY2015Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	97353000	USD
CY2016Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	98634000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	345000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	129000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	134163000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	60000000	USD
CY2015Q2	us-gaap	Restructuring Charges RestructuringCharges	4398000	USD
	us-gaap	Restructuring Charges RestructuringCharges	7861000	USD
CY2016Q2	us-gaap	Restructuring Charges RestructuringCharges	1316000	USD
	us-gaap	Restructuring Charges RestructuringCharges	3932000	USD
CY2016Q2	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	173000	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	345000	USD
CY2015Q2	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	1805000	USD
	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	2258000	USD
CY2016Q2	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	2056000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-601913000	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-619683000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2819000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1990000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	-80878000	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	-18077000	USD
CY2015Q2	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	2186000	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	3350000	USD
CY2015Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2654051	shares
CY2016Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	2761423	shares
CY2015Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10737000	USD
CY2016Q2	us-gaap	Treasury Stock Value TreasuryStockValue	11009000	USD
CY2015Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	68698000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	68668000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	73186000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	70978000	shares

Files In Submission

Name	View Source	Status
0001628280-16-018661-index-headers.html	Edgar Link	pending
0001628280-16-018661-index.html	Edgar Link	pending
0001628280-16-018661.txt	Edgar Link	pending
0001628280-16-018661-xbrl.zip	Edgar Link	pending
bios-20160630.xml	Edgar Link	completed
bios-20160630.xsd	Edgar Link	pending
bios-20160630x10q.htm	Edgar Link	pending
bios-20160630_cal.xml	Edgar Link	unprocessable
bios-20160630_def.xml	Edgar Link	unprocessable
bios-20160630_lab.xml	Edgar Link	unprocessable
bios-20160630_pre.xml	Edgar Link	unprocessable
bios-ex311x20160630x10q.htm	Edgar Link	pending
bios-ex312x20160630x10q.htm	Edgar Link	pending
bios-ex321x20160630x10q.htm	Edgar Link	pending
bios-ex322x20160630x10q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
logowithregisteredtm03.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPCH
Option Care Health, Inc. Stock $opch

2016 Q3 Form 10-Q Financial Statement

#000162828016018661 Filed on August 08, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH Option Care Health, Inc. Stock $opch

2016 Q3 Form 10-Q Financial Statement

#000162828016018661 Filed on August 08, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH
Option Care Health, Inc. Stock $opch